Results 131 to 140 of about 58,231 (302)
Documentary analysis in the study of architectural designs of a hospital in the city of São Paulo [PDF]
Patrícia Bover Draganov +1 more
openalex +1 more source
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha +4 more
wiley +1 more source
The art and science of serious game design: a quasi-experimental study based on self-determination theory in traditional Chinese culture education. [PDF]
Yang J, Li R.
europepmc +1 more source
Yi, Observational Documentary Aesthetics, and the Identity Politics of Transcultural Migrancy
Jiacheng Xu
openalex +2 more sources
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source
Documentary and Gifted Education: <i>Superkids 2</i> and its Impact on Perceptions of Gifted Education and Arts-Based Research. [PDF]
Guryil G +4 more
europepmc +1 more source
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin +12 more
wiley +1 more source
Dialogue through film: engaging midwives, TBAs, and mothers to improve maternal health outcomes in Ghana's Volta region. [PDF]
Koppitz S +3 more
europepmc +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source

